🇺🇸 SODIUM PERTECHNETATE in United States

164 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 47 reports (28.66%)
  2. Radioisotope Scan Abnormal — 36 reports (21.95%)
  3. Bone Scan Abnormal — 14 reports (8.54%)
  4. Product Preparation Error — 14 reports (8.54%)
  5. Scan Myocardial Perfusion Abnormal — 14 reports (8.54%)
  6. Nausea — 10 reports (6.1%)
  7. Radiation Overdose — 8 reports (4.88%)
  8. Vomiting — 8 reports (4.88%)
  9. Diarrhoea — 7 reports (4.27%)
  10. Dyspnoea — 6 reports (3.66%)

Source database →

SODIUM PERTECHNETATE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is SODIUM PERTECHNETATE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for SODIUM PERTECHNETATE in United States?

Marketing authorisation holder not available in our data.